| Health and Wellbeing Research | Lifetime | 45 | KR 13 | 98.69 |
| Palliative Care and End-of-Life Issues | Lifetime | 294 | KR 3 | 98.47 |
| Cancer survivorship and care | Lifetime | 258 | KR 2 | 98.16 |
| Family Support in Illness | Lifetime | 219 | KR 1 | 97.61 |
| Multiple and Secondary Primary Cancers | Lifetime | 310 | KR 5 | 96.89 |
| Patient-Provider Communication in Healthcare | Lifetime | 363 | KR 1 | 96.42 |
| Childhood Cancer Survivors' Quality of Life | Lifetime | 999 | KR 2 | 96.19 |
| Diverse Approaches in Healthcare and Education Studies | Lifetime | 914 | KR 750 | 92.70 |
| Nutrition, Health and Food Behavior | Lifetime | 675 | KR 428 | 91.45 |
| Cardiovascular Health and Risk Factors | Lifetime | 766 | KR 5 | 91.58 |
| Health Promotion and Cardiovascular Prevention | Lifetime | 523 | KR 4 | 90.52 |
| Patient Dignity and Privacy | Lifetime | 503 | KR 7 | 92.11 |
| Alcohol Consumption and Health Effects | 2021-2025 | 55 | KR 2 | 97.09 |
| Liver Disease Diagnosis and Treatment | 2021-2025 | 617 | KR 42 | 97.28 |
| Health and Wellbeing Research | 2021-2025 | 50 | KR 27 | 93.37 |
| Family Support in Illness | 2021-2025 | 112 | KR 3 | 93.84 |
| Cancer Risks and Factors | 2021-2025 | 101 | KR 3 | 94.44 |
| Metabolism, Diabetes, and Cancer | 2021-2025 | 197 | KR 6 | 93.82 |
| Cancer survivorship and care | 2021-2025 | 350 | KR 4 | 93.64 |
| Cancer, Lipids, and Metabolism | 2021-2025 | 363 | KR 7 | 91.26 |
| Childhood Cancer Survivors' Quality of Life | 2021-2025 | 580 | KR 3 | 91.90 |
| Tuberculosis Research and Epidemiology | 2021-2025 | 586 | KR 20 | 92.61 |
| Chronic Obstructive Pulmonary Disease (COPD) Research | 2021-2025 | 915 | KR 40 | 90.34 |
| Diet, Metabolism, and Disease | 2021-2025 | 530 | KR 38 | 87.74 |
| Diverse Approaches in Healthcare and Education Studies | 2021-2025 | 158 | KR 135 | 86.24 |
| Chemotherapy-induced cardiotoxicity and mitigation | 2021-2025 | 289 | KR 4 | 84.47 |
| Folate and B Vitamins Research | 2021-2025 | 312 | KR 7 | 82.82 |
| Nutrition, Health and Food Behavior | 2021-2025 | 94 | KR 73 | 83.46 |
| Diagnosis and treatment of tuberculosis | 2021-2025 | 224 | KR 9 | 84.31 |
| Chronic Disease Management Strategies | 2021-2025 | 898 | KR 7 | 83.88 |
| Smoking Behavior and Cessation | 2021-2025 | 555 | KR 11 | 86.90 |
| Cardiovascular Health and Risk Factors | 2021-2025 | 582 | KR 10 | 82.55 |
| Cardiac Health and Mental Health | 2021-2025 | 939 | KR 20 | 81.21 |
| Health Promotion and Cardiovascular Prevention | 2021-2025 | 222 | KR 6 | 73.38 |
| Cancer-related cognitive impairment studies | 2021-2025 | 894 | KR 23 | 66.20 |
| Peroxisome Proliferator-Activated Receptors | 2021-2025 | 737 | KR 18 | 63.15 |
